Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Physical Review. E|October 21, 2022
Superparamagnetic colloids in a rotating field: Transition state from chains to disksF Mignolet, A Darras, G LumayNeurology|August 1, 1994
Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor GroupJ Hildebrand, T Sahmoud, F Mignolet, et al.Revue D'Epidemiologie Et De Sante Publique|December 30, 2006
[Prevalence of pressure sores in a university hospital in 2003]G Daideri, F Berthier, P Brocker, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancerL V Beex, A R Hermus, G F Pieters, et al.European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG)D Curran, J P van Dongen, N K Aaronson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative GroupR Paridaens, J C Heuson, J P Julien, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: preliminary results of a double-blind randomized study of the EORTC Breast Cancer Cooperative GroupR Paridaens, J C Heuson, J P Julien, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancerJ A van Dongen, H Bartelink, I S Fentiman, et al.British Journal of Cancer|July 2, 1999
Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of CancerJ Vinholes, R Coleman, D Lacombe, et al.Journal of the National Cancer Institute. Monographs|January 1, 1992
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trialJ A van Dongen, H Bartelink, I S Fentiman, et al.Pageof 2